Appendix 3B - Proposed issue of securities Update Summary Entity name PERCHERON THERAPEUTICS LIMITED Announcement Type Update to previous announcement Date of this announcement 4/11/2026 Reason for update to a previous announcement An initial 3B was lodged on 1 September 2026, and the company has...
Update - Proposed issue of securities - PER
Filed with ASX · · 6 pages · English
Release
Percheron Therapeutics Limited on 6ix
Story so far
Earlier from Percheron Therapeutics
- Prospectus - Placement options and JLM options
- FDA Clearance for Vanderbilt Health Clinical Trial in AML
- Listing Rule waiver to allow quotation of PERAQ options
- Completion of HMBD-002 Drug Product Manufacture
- Quarterly Activities Report and Appendix 4C
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics